Background illustration for clinical trials search

Paid Clinical Trials Tuscaloosa

Discover 859 paid clinical trials in Tuscaloosa, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & ResponsiveNew

Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas

for
Neurofibromatosis 1, Plexiform Neurofibroma
Location: Birmingham AL, Cincinnati OH, Dallas TX,
Sponsor: Girish Dhall, MD

Sex: All

Age: 16+

Code: NCT06502171

Phase1, Recruiting
Active & Responsive

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

for
Neuroblastoma, Sarcoma
Location: Birmingham AL, Columbus OH, Washington D.C. DC,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 1 - 40

Code: NCT05135975

Phase2, Recruiting
Active & Responsive

Multisite Implementation of COMPRENDO

for
Pediatric Cancer
Location: Birmingham AL, Boston MA, San Diego CA,
Sponsor: University of California, San Diego

Sex: All

Age: 18+

Code: NCT06055296

Recruiting
Active & Responsive

Evaluation of Accuracy of the Owlet OSS 3.0 Sensor in the Neonatal Population

for
Pulse Oximeter Validation
Location: Birmingham AL, Minneapolis MN
Sponsor: Owlet Baby Care, Inc.

Sex: All

Age: 0

Code: NCT06771206

Recruiting
Active & Responsive

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

for
Pleuropulmonary Blastoma
Location: Birmingham AL, Jackson MS, Pensacola FL, Atlanta GA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT06647953

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

for
Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Location: Birmingham AL, Atlanta GA, St. Petersburg FL,
Sponsor: Electra Therapeutics Inc.

Sex: All

Age: 6+

Code: NCT05416307

Phase2, Phase3, Recruiting
Active & Responsive

Wavelength Intervention for Nearsighted Kids

for
Myopia
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 7 - 12

Code: NCT06598423

Recruiting
Active & Responsive

Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial

for
Myopia
Location: Birmingham AL, Memphis TN, Bloomington IN, Houston TX,
Sponsor: Ohio State University

Sex: All

Age: 6 - 11

Code: NCT07567040

Phase3, Recruiting
Active & Responsive

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

for
Treatment Resistant Depression
Location: Birmingham AL, Atlanta GA, St Louis MO, Charleston SC,
Sponsor: Abbott Medical Devices

Sex: All

Age: 22 - 70

Code: NCT06423430

Recruiting
Active & Responsive

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

for
Major Depressive Disorder (MDD), Depression in Adults,
Location: Birmingham AL, Marietta GA, New Orleans LA,
Sponsor: Cybin IRL Limited

Sex: All

Age: 18 - 70+

Code: NCT06793397

Phase3, Recruiting
Active & Responsive

Retraining and Control Therapy (ReACT): Sense of Control and Symptom Expectations as Targets of a Treatment for PNES

for
Convulsion, Non-Epileptic
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 11 - 18

Code: NCT05096273

Recruiting
Active & Responsive

Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment

for
Non-small Cell Lung Cancer
Location: Birmingham AL, Elizabethtown KY, Tampa FL, New York NY
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06841055

Phase2, Recruiting
Active & Responsive

UAB Alzheimer's Disease Center Core Cohort - Imaging Substudy

for
Alzheimer Disease
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 50+

Code: NCT03503331

Phase2, Recruiting
Active & Responsive

Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome

for
Cascade Testing, Lynch Syndrome, Decision Making,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18+

Code: NCT07106359

Recruiting
Active & Responsive

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer,
Location: Birmingham AL, Atlanta GA, Nashville TN, Knoxville TN,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT06901531

Phase3, Recruiting
Active & Responsive

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

for
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Location: Birmingham AL, Atlanta GA, Franklin TN, Decatur GA,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07198074

Phase3, Recruiting
Active & Responsive

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

for
Glioblastoma, IDH-Wildtype
Location: Birmingham AL, Atlanta GA, Jacksonville FL,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT06319027

Phase2, Recruiting
Active & Responsive

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

for
Glioblastoma (GBM), Newly Diagnosed Glioblastoma, GBM,
Location: Birmingham AL, Atlanta GA, Greenville SC, St Louis MO,
Sponsor: Black Diamond Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07326566

Phase2, Recruiting
Active & Responsive

A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain

for
Diabetic Peripheral Neuropathic Pain
Location: Birmingham AL, Woodstock GA, New Orleans LA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07285018

Phase2, Recruiting
Active & Responsive

A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain

for
Osteoarthritis, Knee, Diabetic Neuropathic Pain,
Location: Birmingham AL, Woodstock GA, New Orleans LA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT05986292

Phase2, Recruiting